|
DE2623228C3
(de)
|
1976-05-24 |
1981-09-10 |
Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren |
N-Acyl-substituierte Benzamide, Verfahren zu ihrer Herstellung und Arzneimittel, enthaltend solche Benzamide
|
|
JPS5587771A
(en)
|
1978-12-27 |
1980-07-02 |
Teikoku Hormone Mfg Co Ltd |
1-phenylisoquinoline derivative
|
|
US4456757A
(en)
|
1981-03-20 |
1984-06-26 |
Asahi Kasei Kogyo Kabushiki Kaisha |
Isoquinolinesulfonyl derivatives and process for the preparation thereof
|
|
JPS5993054A
(ja)
|
1982-11-18 |
1984-05-29 |
Asahi Chem Ind Co Ltd |
イソキノリンスルホン酸アミド誘導体
|
|
DK8386A
(da)
|
1986-01-15 |
1987-07-09 |
Tpo Pharmachim |
Nye n-substituerede 1-benzyl-2-carbamoyltetrahydroisoquinoliner og fremgangsmaade til fremstilling af samme
|
|
EP0266949B1
(en)
|
1986-10-28 |
1990-11-28 |
Smith Kline & French Laboratories Limited |
Tetrahydroisoquinolin-2-yl derivatives of carboxylic acids as thromboxane a2 antagonists
|
|
US4911928A
(en)
|
1987-03-13 |
1990-03-27 |
Micro-Pak, Inc. |
Paucilamellar lipid vesicles
|
|
US5591887A
(en)
|
1987-04-30 |
1997-01-07 |
R-Tech Ueno, Ltd. |
Prostaglandins of the F series
|
|
JPH01139528A
(ja)
|
1987-11-24 |
1989-06-01 |
Showa Denko Kk |
抗潰瘍剤
|
|
EP0569046B1
(en)
|
1988-09-06 |
2002-11-13 |
Pharmacia Aktiebolag |
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
|
|
DK0389995T3
(da)
|
1989-03-28 |
1995-07-03 |
Nisshin Flour Milling Co |
Isoquinolinderivater til behandling af glaukom eller okular hypertension
|
|
KR920008026A
(ko)
|
1990-10-24 |
1992-05-27 |
오노 화아마슈티칼 캄파니 리미팃드 |
이소퀴놀리논 유도체 또는 이의 무독성 산부가염 또는 이의 수화물, 이의 제조방법 및 이를 포함하는 약제 조성물
|
|
US5508288A
(en)
|
1992-03-12 |
1996-04-16 |
Smithkline Beecham, P.L.C. |
Indole derivatives as 5HT1C antagonists
|
|
US5972991A
(en)
|
1992-09-21 |
1999-10-26 |
Allergan |
Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
|
|
DE4332168A1
(de)
|
1993-02-22 |
1995-03-23 |
Thomae Gmbh Dr K |
Cyclische Derivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
US5510383A
(en)
|
1993-08-03 |
1996-04-23 |
Alcon Laboratories, Inc. |
Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
|
|
US6124344A
(en)
|
1993-12-28 |
2000-09-26 |
Allergan Sales, Inc. |
Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
|
|
US5462968A
(en)
|
1994-01-19 |
1995-10-31 |
Allergan, Inc. |
EP2 -receptor agonists as agents for lowering intraocular pressure
|
|
US5698733A
(en)
|
1994-09-30 |
1997-12-16 |
Alcon Laboratories, Inc. |
Use of 9-deoxy prostaglandin derivatives to treat glaucoma
|
|
AU7672096A
(en)
|
1995-06-07 |
1998-06-03 |
Alcon Laboratories, Inc. |
Conformationally rigid aryl- or heteroaryl prostaglandins for use in glaucoma therapy
|
|
US5866602A
(en)
|
1995-12-22 |
1999-02-02 |
Alcon Laboratories, Inc. |
Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
|
|
US5994397A
(en)
|
1995-12-22 |
1999-11-30 |
Alcon Laboratories, Inc. |
Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
|
|
US5814660A
(en)
|
1995-12-22 |
1998-09-29 |
Alcon Laboratories, Inc. |
9-oxa prostaglandin analogs as ocular hypotensives
|
|
US6586425B2
(en)
|
1996-02-21 |
2003-07-01 |
Wisconsin Alumni Research Foundation |
Cytoskeletal active agents for glaucoma therapy
|
|
US5798380A
(en)
|
1996-02-21 |
1998-08-25 |
Wisconsin Alumni Research Foundation |
Cytoskeletal active agents for glaucoma therapy
|
|
DE69714274T3
(de)
|
1996-09-17 |
2006-06-01 |
Asahi Glass Co., Ltd. |
Fluorierte prostaglandinderivate und medikamente
|
|
WO1998020881A1
(en)
|
1996-11-12 |
1998-05-22 |
Alcon Laboratories, Inc |
15-ketal prostaglandins for the treatment of glaucoma or ocular hypertension
|
|
ES2159889T3
(es)
|
1996-11-12 |
2001-10-16 |
Alcon Lab Inc |
15-fluoro prostaglandinas utilizadas como hipotensores oculares.
|
|
CA2269853A1
(en)
|
1996-11-12 |
1998-05-22 |
Paul W. Zinke |
Use of cis-.delta.4 analogs of prostaglandins as ocular hypotensives
|
|
US6353000B1
(en)
|
1996-11-12 |
2002-03-05 |
Alcon Laboratories, Inc. |
11-halo prostaglandins for the treatment of glaucoma or ocular hypertension
|
|
EP0968183A2
(en)
|
1997-03-07 |
2000-01-05 |
Alcon Laboratories, Inc. |
13-thia prostaglandins for use in glaucoma therapy
|
|
AU725677B2
(en)
|
1997-05-09 |
2000-10-19 |
Mount Sinai School Of Medicine Of The City University Of New York, The |
8-iso-prostaglandins for glaucoma therapy
|
|
US5891646A
(en)
|
1997-06-05 |
1999-04-06 |
Duke University |
Methods of assaying receptor activity and constructs useful in such methods
|
|
SE9702706D0
(sv)
|
1997-07-11 |
1997-07-11 |
Pharmacia & Upjohn Ab |
Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma
|
|
US5977173A
(en)
|
1997-09-09 |
1999-11-02 |
Wos; John August |
Aromatic C16 -C20 -substituted tetrahydro prostaglandins useful as FP agonists
|
|
IL134792A0
(en)
|
1997-09-09 |
2001-04-30 |
Procter & Gamble |
Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
|
|
CN1269784A
(zh)
|
1997-09-09 |
2000-10-11 |
普罗克特和甘保尔公司 |
用作fp激活剂的芳香族c16－c20－取代四氢前列腺素
|
|
US5877211A
(en)
|
1997-11-21 |
1999-03-02 |
Allergan |
EP2 receptor agonists as neuroprotective agents for the eye
|
|
AU1709699A
(en)
|
1997-12-22 |
1999-07-12 |
Alcon Laboratories, Inc. |
13-oxa prostaglandins for the treatment of glaucoma and ocular hypertension
|
|
WO2000003736A1
(en)
|
1998-07-14 |
2000-01-27 |
Alcon Laboratories, Inc. |
Prostaglandin product
|
|
TWI249520B
(en)
|
1998-07-15 |
2006-02-21 |
Ono Pharmaceutical Co |
5-Thia-omega-substituted phenyl prostaglandin E derivatives, method for producing the same and medicines containing the same as the active ingredient
|
|
US6720175B1
(en)
|
1998-08-18 |
2004-04-13 |
The Johns Hopkins University School Of Medicine |
Nucleic acid molecule encoding homer 1B protein
|
|
US20020065296A1
(en)
|
1999-01-13 |
2002-05-30 |
Bayer Corporation |
Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
|
|
AU5723500A
(en)
|
1999-05-24 |
2000-12-12 |
Cor Therapeutics, Inc. |
Inhibitors of factor xa
|
|
AU5546000A
(en)
|
1999-06-14 |
2001-01-02 |
Protherics Molecular Design Limited |
Compounds
|
|
JP3910446B2
(ja)
|
1999-11-26 |
2007-04-25 |
塩野義製薬株式会社 |
Ｎｐｙｙ５拮抗剤
|
|
KR100641802B1
(ko)
|
1999-12-28 |
2006-11-02 |
에자이 가부시키가이샤 |
술폰아미드 함유 복소환 화합물
|
|
YU54202A
(sh)
|
2000-01-18 |
2006-01-16 |
Agouron Pharmaceuticals Inc. |
Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
|
|
HN2001000008A
(es)
|
2000-01-21 |
2003-12-11 |
Inc Agouron Pharmaceuticals |
Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
|
|
RU2240826C2
(ru)
|
2000-02-03 |
2004-11-27 |
Эйсай Ко., Лтд. |
Ингибитор экспрессии интегрина
|
|
US6362177B1
(en)
|
2000-05-16 |
2002-03-26 |
Teijin Limited |
Cyclic amine derivatives and their use as drugs
|
|
US6908741B1
(en)
|
2000-05-30 |
2005-06-21 |
Transtech Pharma, Inc. |
Methods to identify compounds that modulate RAGE
|
|
US6855690B2
(en)
|
2000-06-01 |
2005-02-15 |
Children's Medical Center Corporation |
Methods and compositions for treating ocular disorders
|
|
US6323228B1
(en)
|
2000-09-15 |
2001-11-27 |
Abbott Laboratories |
3-substituted indole angiogenesis inhibitors
|
|
US7312358B2
(en)
|
2000-10-17 |
2007-12-25 |
Laboratoires Serono Sa |
Pharmaceutically active sulfanilide derivatives
|
|
US7163800B2
(en)
|
2000-11-03 |
2007-01-16 |
Molecular Devices Corporation |
Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
|
|
JP2004523565A
(ja)
|
2001-03-05 |
2004-08-05 |
トランス テック ファーマ，インコーポレイテッド |
治療因子としてのベンゾイミダゾール誘導体
|
|
CA2443950C
(en)
|
2001-04-20 |
2011-10-18 |
Bayer Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
US6956035B2
(en)
|
2001-08-31 |
2005-10-18 |
Inotek Pharmaceuticals Corporation |
Isoquinoline derivatives and methods of use thereof
|
|
ES2305435T3
(es)
|
2002-01-10 |
2008-11-01 |
Bayer Healthcare Ag |
Inhibidores de la rho-quinasa.
|
|
TW200306819A
(en)
|
2002-01-25 |
2003-12-01 |
Vertex Pharma |
Indazole compounds useful as protein kinase inhibitors
|
|
JP2005526723A
(ja)
|
2002-02-15 |
2005-09-08 |
グラクソ グループ リミテッド |
バニロイド受容体モジュレーター
|
|
WO2003073999A2
(en)
|
2002-03-01 |
2003-09-12 |
Pintex Pharmaceuticals, Inc. |
Pini-modulating compounds and methods of use thereof
|
|
CN101597262A
(zh)
|
2002-03-05 |
2009-12-09 |
特兰斯泰克制药公司 |
抑制配体与高级糖化终产物受体相互作用的单和双环吡咯衍生物
|
|
US7645878B2
(en)
|
2002-03-22 |
2010-01-12 |
Bayer Healthcare Llc |
Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof
|
|
GB0206876D0
(en)
|
2002-03-22 |
2002-05-01 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
JP2005525814A
(ja)
|
2002-05-13 |
2005-09-02 |
ノラック バイオサイエンシズ インコーポレイテッド |
構成的に転位する細胞系
|
|
AU2003257588A1
(en)
|
2002-08-29 |
2004-03-19 |
Santen Pharmaceutical Co., Ltd. |
REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND PROSTAGLANDINS
|
|
WO2004022753A1
(ja)
|
2002-08-30 |
2004-03-18 |
Anges Mg, Inc. |
アクチン関連新規細胞骨格タンパク質ｌａｃｓ
|
|
JPWO2004024717A1
(ja)
|
2002-09-12 |
2006-01-05 |
麒麟麦酒株式会社 |
キナーゼ阻害活性を有するイソキノリン誘導体およびそれを含む医薬
|
|
WO2004037784A2
(en)
|
2002-10-21 |
2004-05-06 |
Irm Llc |
Pyrrolidones with anti-hiv activity
|
|
US7557129B2
(en)
|
2003-02-28 |
2009-07-07 |
Bayer Healthcare Llc |
Cyanopyridine derivatives useful in the treatment of cancer and other disorders
|
|
MXPA05013434A
(es)
|
2003-06-12 |
2006-03-17 |
Astellas Pharma Inc |
Derivados de benzamida o sal del mismo.
|
|
EP1663204B1
(en)
|
2003-08-29 |
2014-05-07 |
Exelixis, Inc. |
C-kit modulators and methods of use
|
|
WO2005037198A2
(en)
|
2003-10-06 |
2005-04-28 |
Glaxo Group Limited |
Preparation of 1,7-disubstituted azabenzimidazoles as kinase inhibitors
|
|
DE10348023A1
(de)
|
2003-10-15 |
2005-05-19 |
Imtm Gmbh |
Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
|
|
JP2007008816A
(ja)
|
2003-10-15 |
2007-01-18 |
Ube Ind Ltd |
新規イソキノリン誘導体
|
|
JP4110324B2
(ja)
|
2003-10-15 |
2008-07-02 |
宇部興産株式会社 |
新規インダゾール誘導体
|
|
SE0400284D0
(sv)
|
2004-02-10 |
2004-02-10 |
Astrazeneca Ab |
Novel compounds
|
|
JP2005227441A
(ja)
|
2004-02-12 |
2005-08-25 |
Konica Minolta Medical & Graphic Inc |
光熱写真画像形成材料
|
|
US7592357B2
(en)
|
2004-02-20 |
2009-09-22 |
Smithkline Beecham Corporation |
Compounds
|
|
US20080096238A1
(en)
|
2004-03-30 |
2008-04-24 |
Alcon, Inc. |
High throughput assay for human rho kinase activity with enhanced signal-to-noise ratio
|
|
DE102004017438A1
(de)
|
2004-04-08 |
2005-11-03 |
Bayer Healthcare Ag |
Hetaryloxy-substituierte Phenylaminopyrimidine
|
|
US7453002B2
(en)
|
2004-06-15 |
2008-11-18 |
Bristol-Myers Squibb Company |
Five-membered heterocycles useful as serine protease inhibitors
|
|
WO2006009889A1
(en)
|
2004-06-17 |
2006-01-26 |
Smithkline Beecham Corporation |
Novel inhibitors of rho-kinases
|
|
EP1607840B1
(en)
|
2004-06-18 |
2015-01-28 |
Tobii Technology AB |
Eye control of computer apparatus
|
|
MX2007002312A
(es)
|
2004-08-26 |
2007-04-16 |
Pfizer |
Compuestos de aminoheteroarilo enantiomericamente puros como inhibidores de proteina quinasa.
|
|
US20080132507A1
(en)
|
2004-10-13 |
2008-06-05 |
Eisai R&D Management Co., Ltd. |
Hydrazide Derivatives
|
|
UY29198A1
(es)
|
2004-11-09 |
2006-05-31 |
Cancer Rec Tech Ltd |
Derivados sustituidos de quinazolinona y derivados sustituidos de quinazolina-2, 4-diona, composiciones conteniéndolos, procedimientos de preparación y aplicaciones
|
|
GB0425026D0
(en)
|
2004-11-12 |
2004-12-15 |
Biofocus Discovery Ltd |
Compounds which bind to the active site of protein kinase enzymes
|
|
WO2006062982A2
(en)
|
2004-12-07 |
2006-06-15 |
Locus Pharmaceuticals, Inc. |
Urea inhibitors of map kinases
|
|
US20080207677A1
(en)
|
2004-12-31 |
2008-08-28 |
Gpc Biotech Ag |
Napthyridine Compounds As Rock Inhibitors
|
|
US7652041B2
(en)
|
2005-01-14 |
2010-01-26 |
Millennium Pharmaceuticals, Inc. |
Cinnamide and hydrocinnamide derivatives with kinase inhibitory activity
|
|
WO2006081554A2
(en)
*
|
2005-01-28 |
2006-08-03 |
Irm Llc |
Phenyl-substituted pyrrolidones
|
|
WO2006086562A2
(en)
|
2005-02-09 |
2006-08-17 |
Microbia, Inc. |
Phenylazetidinone derivatives
|
|
MX2007014774A
(es)
|
2005-05-25 |
2008-02-19 |
Wyeth Corp |
Metodos para sintetizar derivados de 6-alquilaminoquinolina.
|
|
WO2007008942A2
(en)
|
2005-07-11 |
2007-01-18 |
Aerie Pharmaceuticals, Inc. |
Phenylamino-acetic acid [1-(pyridin-4-yl)-methylidene]-hydrazide derivatives and related compounds as modulators of g protein-coupled receptor kinases for the treatment of eye diseases
|
|
WO2007008926A1
(en)
|
2005-07-11 |
2007-01-18 |
Aerie Pharmaceuticals, Inc. |
Isoquinoline compounds
|
|
ATE551059T1
(de)
|
2005-10-26 |
2012-04-15 |
Asahi Kasei Pharma Corp |
Fasudil in kombination mit bosentan zur behandlung von pulmonaler arterieller hypertonie
|
|
TW200738682A
(en)
|
2005-12-08 |
2007-10-16 |
Organon Nv |
Isoquinoline derivatives
|
|
RU2008130111A
(ru)
|
2005-12-22 |
2010-01-27 |
Алькон Рисерч, Лтд. (Us) |
(индазол-5-ил)пиразины и (1,3-дигидроиндол-2-он)пиразины для лечения опосредованнызх rно-киназой заболеваний и состояний
|
|
AR057252A1
(es)
|
2005-12-27 |
2007-11-21 |
Alcon Mfg Ltd |
Inhibicion de rho quinasa mediada por arni para el tratamiento de trastornos oculares
|
|
PT2420491E
(pt)
|
2005-12-30 |
2013-10-14 |
Novartis Ag |
Compostos de piperidina 3,5-substituída como inibidores de renina
|
|
KR101452520B1
(ko)
|
2006-01-27 |
2014-10-21 |
샹하이 헨그루이 파마수티컬 컴퍼니 리미티드 |
피롤로[3,2-ｃ]피리딘-4-온 2-인돌린온 단백질 키나제 억제제
|
|
JP5476559B2
(ja)
|
2006-02-10 |
2014-04-23 |
国立大学法人九州大学 |
リン酸化酵素の新規基質ポリペプチド
|
|
US7625927B2
(en)
|
2006-02-27 |
2009-12-01 |
Alcon Research, Ltd. |
Method of treating glaucoma
|
|
EP1991531A1
(en)
|
2006-02-28 |
2008-11-19 |
Amgen Inc. |
Cinnoline and quinoxaline derivates as phosphodiesterase 10 inhibitors
|
|
JP2007246466A
(ja)
|
2006-03-17 |
2007-09-27 |
Osaka Univ |
中枢神経損傷に対する嗅粘膜移植にＲｈｏキナーゼ阻害剤を用いた神経機能再建法
|
|
CA2653424A1
(en)
|
2006-06-08 |
2007-12-13 |
Ube Industries, Ltd. |
Novel indazole derivative having spiro ring structure in side chain
|
|
BRPI0713187A2
(pt)
|
2006-07-20 |
2012-10-16 |
Mehmet Kahraman |
método de inibir rho-quinase, método de tratamento de doença mediada por rho-quinase, composto e composição farmacêutica
|
|
US20090318485A1
(en)
*
|
2006-07-20 |
2009-12-24 |
Kalypsys, Inc. |
Novel inhibitors of rho kinase
|
|
MX2009001037A
(es)
|
2006-07-31 |
2009-05-15 |
Senju Pharma Co |
Preparacion liquida acuosa que contiene compuesto de amida.
|
|
CA2664335C
(en)
|
2006-09-20 |
2014-12-02 |
Boehringer Ingelheim International Gmbh |
Rho kinase inhibitors
|
|
US20110039893A1
(en)
*
|
2006-10-11 |
2011-02-17 |
Takeda Pharmaceutical Company Limited |
Gsk-3beta inhibitor
|
|
US8949825B1
(en)
|
2006-10-17 |
2015-02-03 |
Manageiq, Inc. |
Enforcement of compliance policies in managed virtual systems
|
|
WO2008049000A2
(en)
|
2006-10-18 |
2008-04-24 |
United Therapeutics Corporation |
Combination therapy for pulmonary arterial hypertension
|
|
WO2008049919A2
(en)
|
2006-10-26 |
2008-05-02 |
Devgen N.V. |
Rho kinase inhibitors
|
|
US8071779B2
(en)
|
2006-12-18 |
2011-12-06 |
Inspire Pharmaceuticals, Inc. |
Cytoskeletal active rho kinase inhibitor compounds, composition and use
|
|
WO2008079945A2
(en)
|
2006-12-20 |
2008-07-03 |
University Of South Florida |
Rock inhibitors and uses thereof
|
|
AR064420A1
(es)
|
2006-12-21 |
2009-04-01 |
Alcon Mfg Ltd |
Composiciones farmaceuticas oftalmicas que comprenden una cantidad efectiva de analogos de 6-aminoimidazo[1,2b]piridazinas, utiles para el tratamiento del glaucoma y/o controlar la presion intraocular normal o elevada(iop).
|
|
BRPI0720909A2
(pt)
|
2006-12-27 |
2016-11-01 |
Sanofi Aventis |
derivados de isoquinolina e isoquinolinona substituídos
|
|
DE602007013950D1
(de)
|
2006-12-27 |
2011-05-26 |
Sanofi Aventis |
Cycloalkylaminsubstituierte isochinolon- und isochinolinonderivate
|
|
EP2125746B1
(en)
|
2006-12-27 |
2012-04-18 |
Sanofi |
Cycloalkylamine substituted isoquinoline derivatives
|
|
RU2457203C2
(ru)
|
2006-12-27 |
2012-07-27 |
Санофи-Авентис |
Замещенные циклоалкиламином производные изохинолона
|
|
AU2007338412B2
(en)
|
2006-12-27 |
2013-03-14 |
Sanofi-Aventis |
Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives
|
|
NZ577981A
(en)
|
2006-12-27 |
2011-12-22 |
Sanofi Aventis |
Substituted isoquinoline and isoquinolinone derivatives as inhibitors of rho-kinase
|
|
MX2009006517A
(es)
|
2006-12-27 |
2009-06-26 |
Sanofi Aventis |
Nuevos derivados de isoquinolina e isoquinolinona sustituidos.
|
|
US8455513B2
(en)
|
2007-01-10 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-aminoisoquinoline compounds
|
|
WO2008105058A1
(ja)
|
2007-02-27 |
2008-09-04 |
Asahi Kasei Pharma Corporation |
スルホンアミド化合物
|
|
US20100063282A1
(en)
|
2007-04-10 |
2010-03-11 |
Boehringer Ingelheim International Gmbh |
Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions, and Uses Thereof
|
|
CN101801955B
(zh)
|
2007-07-05 |
2013-05-08 |
阵列生物制药公司 |
作为akt蛋白激酶抑制剂的嘧啶基环戊烷
|
|
PT2217572E
(pt)
*
|
2007-11-16 |
2014-02-17 |
Vertex Pharma |
Moduladores de isoquinolina de transportadores de cassete de ligação a atp
|
|
US8455514B2
(en)
|
2008-01-17 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-and 7-amino isoquinoline compounds and methods for making and using the same
|
|
US8450344B2
(en)
|
2008-07-25 |
2013-05-28 |
Aerie Pharmaceuticals, Inc. |
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
|
|
JP2012500219A
(ja)
|
2008-08-15 |
2012-01-05 |
エヌサーティー・ファーマシューティカルズ，エルエルシー |
治療薬剤としての、ｓ−ニトロソグルタチオンレダクターゼの新規ピロール阻害剤
|
|
ES2553827T3
(es)
*
|
2009-05-01 |
2015-12-14 |
Aerie Pharmaceuticals, Inc. |
Inhibidores de mecanismo doble para el tratamiento de enfermedad
|
|
CA2764124C
(en)
|
2009-06-19 |
2016-12-13 |
D. Western Therapeutics Institute, Inc. |
Substituted isoquinoline derivative
|
|
WO2011085351A2
(en)
|
2010-01-11 |
2011-07-14 |
The Johns Hopkins University |
Method of treating kcnq related disorders
|
|
FR2961694B1
(fr)
|
2010-06-29 |
2013-01-25 |
Thea Lab |
Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur
|
|
US20130296363A1
(en)
|
2010-09-01 |
2013-11-07 |
Ambit Biosciences Corporation |
Quinoline and isoquinoline derivatives for use as jak modulators
|
|
RU2013117209A
(ru)
|
2010-11-08 |
2014-10-27 |
Хилор Лтд. |
Буферные глазные композиции и способы их применения
|
|
TW202344254A
(zh)
|
2011-02-04 |
2023-11-16 |
日商興和股份有限公司 |
青光眼或高眼壓症之預防或治療用之醫藥
|
|
JP2013035802A
(ja)
|
2011-08-10 |
2013-02-21 |
D Western Therapeutics Institute Inc |
緑内障又は高眼圧症の予防又は治療剤
|
|
EP2671883A1
(en)
|
2012-06-05 |
2013-12-11 |
Bioprojet |
New 6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands
|
|
JP2014019650A
(ja)
|
2012-07-13 |
2014-02-03 |
Santen Pharmaceut Co Ltd |
スルホンアミド化合物とタフルプロストの組み合わせ
|
|
WO2014019023A1
(en)
*
|
2012-08-01 |
2014-02-06 |
Bionomics Limited |
α7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS AND USES THEREOF-I
|
|
CN105051005B
(zh)
*
|
2012-10-12 |
2017-06-13 |
武田药品工业株式会社 |
环丙胺化合物及其用途
|
|
HUE061618T2
(hu)
|
2013-03-15 |
2023-07-28 |
Aerie Pharmaceuticals Inc |
Vegyület szemrendellenességek kezelésére
|
|
AU2015289044A1
(en)
|
2014-07-17 |
2016-12-08 |
Cancer Research Technology Limited |
Novel naphthryidines and isoquinolines and their use as CDK8/19 inhibitors
|
|
US10227343B2
(en)
|
2015-01-30 |
2019-03-12 |
Vanderbilt University |
Isoquiniline and napthalene-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
|
|
US9770466B2
(en)
|
2015-07-02 |
2017-09-26 |
Veloce Biopharma, Llc |
Ophthalmic composition and methods of use
|
|
US9643927B1
(en)
|
2015-11-17 |
2017-05-09 |
Aerie Pharmaceuticals, Inc. |
Process for the preparation of kinase inhibitors and intermediates thereof
|
|
US9963432B2
(en)
|
2016-08-19 |
2018-05-08 |
Aerie Pharmaceuticals, Inc. |
Beta-amino-isoquinolinyl amide compounds
|
|
WO2018045091A1
(en)
|
2016-08-31 |
2018-03-08 |
Aerie Pharmaceuticals, Inc. |
Ophthalmic compositions
|
|
JP2020515583A
(ja)
*
|
2017-03-31 |
2020-05-28 |
アエリエ ファーマシューティカルズ インコーポレイテッド |
アリールシクロプロピル−アミノ−イソキノリニルアミド化合物
|
|
BR112020020008A2
(pt)
|
2018-03-30 |
2021-01-05 |
Aerie Pharmaceuticals, Inc. |
Sais mono ácido de 6-aminoisoquinolinas e seus usos
|
|
AU2019337703B2
(en)
*
|
2018-09-14 |
2023-02-02 |
Aerie Pharmaceuticals, Inc. |
Aryl cyclopropyl-amino-isoquinolinyl amide compounds
|